Literature DB >> 29417466

Lanostane triterpenoids from Fomitopsis officinalis and their trypanocidal activity.

Shinen Naranmandakh1, Toshihiro Murata2, Batsukh Odonbayar3, Keisuke Suganuma4, Javzan Batkhuu5, Kenroh Sasaki3.   

Abstract

Fomitopsis officinalis is a medicinal fungus, known as 'Agarikon', and is used traditionally in the treatment of asthma and rheumatism in Mongolia. The investigation of the chemical constituents of F. officinalis led to the isolation of 4 new lanostane triterpenoids together with 4 known triterpenoids. Inhibitory activity against Trypanosoma congolense, which causes fatal diseases in animals including livestock, was estimated for the isolated compounds. Compounds 2-5 and 8 exhibited moderate inhibition activities with IC50 values ranging from 7.0-27.1 µM.

Entities:  

Keywords:  Agarikon; Fomitopsis officinalis; Lanostane triterpenoid; Mongolia; Traditional medicinal mushroom; Trypanosoma

Mesh:

Substances:

Year:  2018        PMID: 29417466     DOI: 10.1007/s11418-018-1182-1

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  12 in total

1.  Four new triterpenes from fungus of Fomes officinalis.

Authors:  Xia Wu; Jun-Shan Yang; Ming Yan
Journal:  Chem Pharm Bull (Tokyo)       Date:  2009-02       Impact factor: 1.645

Review 2.  European medicinal polypores--a modern view on traditional uses.

Authors:  Ulrike Grienke; Margit Zöll; Ursula Peintner; Judith M Rollinger
Journal:  J Ethnopharmacol       Date:  2014-04-28       Impact factor: 4.360

3.  Lanostane triterpenoids from the inedible mushroom Fomitopsis spraguei.

Authors:  Dang Ngoc Quang; Yuuki Arakawa; Toshihiro Hashimoto; Yoshinori Asakawa
Journal:  Phytochemistry       Date:  2005-07       Impact factor: 4.072

4.  Trypanocidal Activity of 2,5-Diphenyloxazoles Isolated from the Roots of Oxytropis lanata.

Authors:  Orkhon Banzragchgarav; Toshihiro Murata; Gendaram Odontuya; Buyanmandakh Buyankhishig; Keisuke Suganuma; Bekh-Ochir Davaapurev; Noboru Inoue; Javzan Batkhuu; Kenroh Sasaki
Journal:  J Nat Prod       Date:  2016-10-31       Impact factor: 4.050

5.  New lanostane-type triterpenes from Fomes officinalis.

Authors:  Xia Wu; JunShan Yang; Liang Zhou; YueSheng Dong
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-11       Impact factor: 1.645

6.  Anti-inflammatory lanostane-type triterpene acids from Piptoporus betulinus.

Authors:  Tsunashi Kamo; Masashi Asanoma; Hisao Shibata; Mitsuru Hirota
Journal:  J Nat Prod       Date:  2003-08       Impact factor: 4.050

7.  In vitro cultivation of Trypanosoma congolense bloodstream forms in the absence of feeder cell layers.

Authors:  H Hirumi; K Hirumi
Journal:  Parasitology       Date:  1991-04       Impact factor: 3.234

8.  Chlorinated coumarins from the polypore mushroom Fomitopsis officinalis and their activity against Mycobacterium tuberculosis.

Authors:  Chang Hwa Hwang; Birgit U Jaki; Larry L Klein; David C Lankin; James B McAlpine; José G Napolitano; Nicole A Fryling; Scott G Franzblau; Sang Hyun Cho; Paul E Stamets; Yuehong Wang; Guido F Pauli
Journal:  J Nat Prod       Date:  2013-10-02       Impact factor: 4.050

9.  Officimalonic acids A-H, lanostane triterpenes from the fruiting bodies of Fomes officinalis.

Authors:  Jianxin Han; Liya Li; Jialiang Zhong; Zeynep Tohtaton; Qing Ren; Li Han; Xueshi Huang; Tao Yuan
Journal:  Phytochemistry       Date:  2016-05-20       Impact factor: 4.072

10.  Establishment of ATP-based luciferase viability assay in 96-well plate for Trypanosoma congolense.

Authors:  Keisuke Suganuma; Puttik Allamanda; Hassan Hakimi; Mo Zhou; Jose Ma Angeles; Shin-ichiro Kawazu; Noboru Inoue
Journal:  J Vet Med Sci       Date:  2014-07-23       Impact factor: 1.267

View more
  1 in total

Review 1.  Biological activity evaluations of chemical constituents derived from Mongolian medicinal forage plants and their applications in combating infectious diseases and addressing health problems in humans and livestock.

Authors:  Toshihiro Murata; Javzan Batkhuu
Journal:  J Nat Med       Date:  2021-05-21       Impact factor: 2.343

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.